GeneDx Holdings Corp. (WGS)
USD 76.93
(-2.87%)
USD 76.93
(-2.87%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -180.14 Million | -319.15 Million | -190.43 Million | -93.12 Million | -18.72 Million |
| Net Income | -175.76 Million | -548.98 Million | -245.39 Million | -241.34 Million | -29.7 Million |
| Depreciation & Amortization | 35.83 Million | 59.3 Million | 21.8 Million | 11.73 Million | 6.4 Million |
| Deferred income taxes | -926 Thousand | -49.12 Million | -195.97 Million | - | - |
| Stock-based compensation | -326 Thousand | 41.97 Million | 219.42 Million | 120.23 Million | 5.48 Million |
| Change in working capital | -38.24 Million | 36.13 Million | 8.07 Million | 13.84 Million | -737 Thousand |
| Other non-cash items | -721 Thousand | 141.53 Million | 1.62 Million | 2.4 Million | -176 Thousand |
| Investing Cash Flow | -43.72 Million | -141.32 Million | -20.78 Million | -31.97 Million | -15.45 Million |
| Investments in PPE | -5.71 Million | -14.32 Million | -20.78 Million | -31.97 Million | -15.45 Million |
| Acquisitions | -8.1 Million | -127 Million | - | - | - |
| Investment purchases | -47.67 Million | - | - | - | - |
| Sales/Maturities of investments | 17.76 Million | - | - | - | - |
| Other Investing Activities | -1.00 | - | - | - | - |
| Financing Cash Flow | 186.23 Million | 197.31 Million | 493.72 Million | 129.05 Million | 148.01 Million |
| Debt repayment | -42.95 Million | -3.29 Million | -13.46 Million | -4.19 Million | -1.7 Million |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | 143.28 Million | 200.6 Million | 442.68 Million | 117.32 Million | - |
| Other Financing Activities | 85.9 Million | 197.65 Million | 64.51 Million | 15.92 Million | 149.72 Million |
| Accounts receivables | 10.26 Million | 5.52 Million | 5.53 Million | -10.61 Million | -4.56 Million |
| Accounts payables | -46.95 Million | 34.45 Million | 13.04 Million | 34.43 Million | 10.37 Million |
| Inventory | 975 Thousand | 4.6 Million | -10.62 Million | -8.97 Million | -7.97 Million |
| Other working capital | -2.52 Million | -8.45 Million | 123 Thousand | -1 Million | 1.42 Million |
| Cash at beginning of period | 137.4 Million | 401.46 Million | 118.96 Million | 115 Million | 1.17 Million |
| Cash at end of period | 99.68 Million | 138.3 Million | 401.46 Million | 118.96 Million | 115 Million |
| Capital Expenditure | -5.71 Million | -14.32 Million | -20.78 Million | -31.97 Million | -15.45 Million |
| Effect of forex changes on cash | -87 Thousand | - | - | - | - |
| Net cash flow / Change in cash | -37.72 Million | -263.16 Million | 282.5 Million | 3.95 Million | 113.82 Million |
| Free Cash Flow | -185.85 Million | -333.47 Million | -211.22 Million | -125.1 Million | -34.18 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -70.54 Million | -29.17 Million | -20.23 Million | -25.77 Million | -175.76 Million | -42.28 Million |
| Depreciation & Amortization | 16.39 Million | 5.51 Million | 5.64 Million | 6.69 Million | 35.83 Million | 8.67 Million |
| Deferred income taxes | -319 Thousand | -190 Thousand | -82 Thousand | -411 Thousand | -926 Thousand | -172 Thousand |
| Stock-based compensation | 6.29 Million | 3.1 Million | -451 Thousand | -912 Thousand | -326 Thousand | 430 Thousand |
| Change in working capital | 1.72 Million | -3.54 Million | -7.68 Million | -8.36 Million | -38.24 Million | -14.44 Million |
| Other non-cash items | 22.08 Million | 35.67 Million | 20.62 Million | -1.09 Million | -721 Thousand | 6.82 Million |
| Investing Cash Flow | -29.61 Million | -22.7 Million | 843 Thousand | -4.86 Million | -43.72 Million | -27.37 Million |
| Investments in PPE | -2.44 Million | -1.35 Million | -443 Thousand | -2.37 Million | -5.71 Million | -112 Thousand |
| Acquisitions | - | - | - | 147 Thousand | -8.1 Million | 253 Thousand |
| Investment purchases | -52.72 Million | -24.21 Million | -5.16 Million | -3.73 Million | -47.67 Million | -43.93 Million |
| Sales/Maturities of investments | 25.55 Million | 2.86 Million | 6.45 Million | 1.1 Million | 17.76 Million | 16.66 Million |
| Other Investing Activities | - | - | - | 147 Thousand | -1.00 | -250 Thousand |
| Financing Cash Flow | 13.16 Million | -391 Thousand | -438 Thousand | 47.1 Million | 186.23 Million | -911 Thousand |
| Debt repayment | -1.49 Million | -528 Thousand | -462 Thousand | -47.08 Million | -42.95 Million | -911 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 14.67 Million | 137 Thousand | 24 Thousand | 19 Thousand | 143.28 Million | - |
| Other Financing Activities | 14.66 Million | 137 Thousand | - | 94.16 Million | 85.9 Million | - |
| Accounts receivables | -5.85 Million | 2.65 Million | 4.22 Million | -463 Thousand | 10.26 Million | 802 Thousand |
| Accounts payables | -7.8 Million | -5.62 Million | -4.73 Million | -7.04 Million | -46.95 Million | -14.79 Million |
| Inventory | -2.13 Million | 1.22 Million | -2.87 Million | 293 Thousand | 975 Thousand | 1.16 Million |
| Other working capital | 4.89 Million | -1.79 Million | -4.29 Million | -1.15 Million | -2.52 Million | -1.62 Million |
| Cash at beginning of period | 167.95 Thousand | 83.67 Million | 99.68 Million | 87.38 Million | 137.4 Million | 157.55 Million |
| Cash at end of period | 58.88 Million | 56.07 Million | 83.67 Million | 99.68 Million | 99.68 Million | 88.28 Million |
| Capital Expenditure | -2.44 Million | -1.35 Million | -443 Thousand | -2.37 Million | -5.71 Million | -112 Thousand |
| Effect of forex changes on cash | - | - | - | -87 Thousand | -87 Thousand | - |
| Net cash flow / Change in cash | 58.71 Million | -27.59 Million | -16 Million | 12.29 Million | -37.72 Million | -69.26 Million |
| Free Cash Flow | -26.8 Million | -5.85 Million | -16.85 Million | -32.23 Million | -185.85 Million | -41.09 Million |
MIELY
PRGO
AIRE
1944
MFON
6144